莫德纳CEO：明年年中全球疫苗够用，疫情有望在一年内结束_老虎社区_美港股上老虎

莫德纳CEO：明年年中全球疫苗够用，疫情有望在一年内结束

新浪财经2021-09-24

财联社（上海，编辑史正丞）讯，据媒体周四报道，生物制药企业莫德纳CEO Stéphane Bancel在接受《新苏黎世报》采访时表示，随着不断提升的全球疫苗产能覆盖需求，新冠疫情有望在一年内结束。在专访中，Stéphane表示鉴于过去六个月全行业产能的扩张，到明年年中应该会有足够的剂量供应地球上每个人接种疫苗，加强接种应该也可以达到所需的程度。此外，在德尔塔变异毒株超强传染性的背景下，那些不...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

神话者
·2021-09-24
[微笑]
回复
1
举报
收起
- 中国ChinaATM:
  的
  2021-09-24
  回复
  举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2169346695?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/a83b39655f16e786ad10ee3d9f0978cc","is_english":false,"pubTime":"2021-09-24 07:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2169346695","market":"hk","top_or_hot":-1,"title":"莫德纳CEO：明年年中全球疫苗够用，疫情有望在一年内结束","media":"新浪财经","content":"<div>\n<p>财联社（上海，编辑 史正丞）讯，据媒体周四报道，生物制药企业莫德纳CEO Stéphane Bancel在接受《新苏黎世报》采访时表示，随着不断提升的全球疫苗产能覆盖需求，新冠疫情有望在一年内结束。\n在专访中，Stéphane表示鉴于过去六个月全行业产能的扩张，到明年年中应该会有足够的剂量供应地球上每个人接种疫苗，加强接种应该也可以达到所需的程度。此外，在德尔塔变异毒株超强传染性的背景下，那些不...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-09-24/doc-iktzqtyt7728803.shtml\">网页链接</a>\n\n</div>\n","source":"sina_us","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>莫德纳CEO：明年年中全球疫苗够用，疫情有望在一年内结束</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n莫德纳CEO：明年年中全球疫苗够用，疫情有望在一年内结束\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-24 07:58 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2021-09-24/doc-iktzqtyt7728803.shtml><strong>新浪财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>财联社（上海，编辑 史正丞）讯，据媒体周四报道，生物制药企业莫德纳CEO Stéphane Bancel在接受《新苏黎世报》采访时表示，随着不断提升的全球疫苗产能覆盖需求，新冠疫情有望在一年内结束。\n在专访中，Stéphane表示鉴于过去六个月全行业产能的扩张，到明年年中应该会有足够的剂量供应地球上每个人接种疫苗，加强接种应该也可以达到所需的程度。此外，在德尔塔变异毒株超强传染性的背景下，那些不...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2021-09-24/doc-iktzqtyt7728803.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2021-09-24/doc-iktzqtyt7728803.shtml","article_id":"2169346695","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/a83b39655f16e786ad10ee3d9f0978cc"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2169346695","pubTimestamp":1632441492,"sourceInfo":{"source_id":"sina_us","name":"新浪美股"},"weMediaInfo":null,"summary":"　　财联社 讯，据媒体周四报道，生物制药企业莫德纳CEO Stéphane Bancel在接受《新苏黎世报》采访时表示，随着不断提升的全球疫苗产能覆盖需求，新冠疫情有望在一年内结束。他透露目前正在临床试验中测试针对Delta病毒优化的变体，将成为2022年加强疫苗接种的基础。Stéphane同时表示，调整后的疫苗依旧能在老生产线上生产，价格也不会发生变化。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"CEO of Mardner: There will be enough vaccines in the world in the middle of next year, and the epidemic is expected to end within one year","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/a189d01e987351d85336f19d50b2aba5","symbols_score_info":{"MRNA":0.9},"content_text":"财联社（上海，编辑 史正丞）讯，据媒体周四报道，生物制药企业莫德纳CEO Stéphane Bancel在接受《新苏黎世报》采访时表示，随着不断提升的全球疫苗产能覆盖需求，新冠疫情有望在一年内结束。\n在专访中，Stéphane表示鉴于过去六个月全行业产能的扩张，到明年年中应该会有足够的剂量供应地球上每个人接种疫苗，加强接种应该也可以达到所需的程度。此外，在德尔塔变异毒株超强传染性的背景下，那些不接种疫苗的人群最终也会通过感染获得自然免疫。后续的进展可能与流感一样，要么接种疫苗，要么冒着感染甚至住院的风险。\n在被问及这段话是否意味着明年下半年世界有望走出疫情阴影时，Stéphane给出了肯定的回答。\n此外，在最近非常火热的加强针接种问题上，Stéphane预期各国政府将给予放行，给去年最早一批接种疫苗的高危人群加强免疫。此外，莫德纳疫苗加强针的剂量仅为原始针的一半，意味着更多人能够得到接种。Stéphane表示，疫苗的数量是最大的限制因素。如果剂量减半，未来一年我们将在全球范围内提供30亿剂，而不仅仅是20亿剂。\nStéphane也对“加强剂为何不改变配方”进行了回应，强调公司缺乏足够的时间做出改变。他透露目前正在临床试验中测试针对Delta病毒优化的变体，将成为2022年加强疫苗接种的基础。公司也在尝试同时应对Delta和Beta变种的疫苗。Stéphane同时表示，调整后的疫苗依旧能在老生产线上生产，价格也不会发生变化。","kind":"highlight","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":861037491,"gmtCreate":1632441671613,"gmtModify":1632725594327,"author":{"id":"4090235052856760","authorId":"4090235052856760","name":"神话者","avatar":"https://static.tigerbbs.com/8b20ae15ae6c2600ed63bffb924fc3d1","vip":1,"hat":"https://static.tigerbbs.com/622fc56f7e67b5729addb4e78a195511","crmLevel":2,"crmLevelSwitch":0,"idStr":"4090235052856760","authorIdStr":"4090235052856760"},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/861037491","repostId":2169346695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5976557,"gmtCreate":1632442248160,"gmtModify":1634787666908,"authorId":3584867430360256,"author":{"id":3584867430360256,"idStr":"3584867430360256","authorId":3584867430360256,"name":"中国ChinaATM","avatar":"https://static.tigerbbs.com/bd214125064b4d25501bb48cef2fb529","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":861037491,"type":1,"supId":0,"prevId":0,"content":"的","text":"的","html":"的"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":17,"commentSize":1,"repostSize":0,"favoriteSize":2,"likeStatus":false,"favoriteStatus":false}}